EPID-17. A SINGLE CENTER RESTROSPECTIVE REVIEW OF RECURRENT OR TREATMENT REFRACTORY PEDIATRIC MEDULLOBLASTOMA

The outcome of pediatric refractory or relapsed brain tumours remains a concern for treating neurooncology teams with the most effective salvage therapy yet to be established. Upfront therapy for primary medulloblastoma (MB) is dependent on age, post-operative residual and evidence of metastasis at diagnosis. Children diagnosed with aggressive subtypes of MB that are refractory to upfront therapy or recur either in the resection cavity or as …